Growing technological needs in pharma

Growing technological needs in pharma

Eighth international symposium on ‘Advances in technology and business potential of new drug delivery systems’ concluded successfully in Gujarat. Sachin Jagdale reports

The Indian chapter of the Controlled Release Society – (CRS-IC) recently organised the eighth international symposium on ‘Advances in technology and business potential of new drug delivery systems’ on 26th and 27th February 2008, at B V Patel Pharmaceutical Education and Research Department (PERD) centre, Thaltej-Gandhinagar, Gujarat.

Since the inception of CRS-IC in 1993 it has metamorphosed into one of the major platforms for the scientists from different fields like academia, industry and regulatory agencies to put their views on New Drug delivery Systems (NDDS). This year’s symposium was not an exception to this. There were eminent scientists from reputed organisations. This symposium was focussed on the holistic approach in the design of new drug delivery systems. Poster sessions depicting research in drug delivery were the highlight of the event. Such research is currently going on in different educational, governmental and industrial labs. Exhibition showing core technologies, services related to drug delivery system had also managed to garner attention of the visitors.

The symposium covered a wide array of topics. One of the speakers, Professor Leslie Benet, spoke on advances in technology and business potential of NDDS, including recent advances in biopharmaceutics, biopharmaceutics classification system (BCS) and biopharmaceutics drug disposition classification system (BDDCS). BCS was developed to allow prediction of in vivo pharmacokinetic performance of drug products from measurements of permeability and solubility whereas BDDCS may be useful in predicting overall drug disposition. Professor Michael S Roberts, Director of The University of Queensland’s therapeutics research unit (TRU) based at Princess Alexandra

Hospital (PAH) gave a lecture on targeted topical drug delivery, which was very informative. Roberts opined on chemical structure-vehicle formulation-skin transport relation-ship for the absorption of drugs and toxins through the skin and it’s necessity in development of dermatological products. He said, “Our interest lies in flourishing these relationships.” CRS-IC has grown under the guidance of many able leaders. Current president of CRS-IC, Ajit Singh, was visibly pleased with the response for the symposium. He said, “I am very satisfied with the response that we got. It was a full house. Many industry veterans, academicians from India and overseas attended the event. It was a valuable learning experience for those who were there for the symposium.”